Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiangfeng Wang

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Scientific Reports|November 21, 2025
Research on vehicle trajectory planning algorithm integrating spatiotemporal constraints and adaptive curvatureYatao Zhao, Jiangfeng Wang, Peikun Li, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 7, 2025
HER2-targeted agents and interstitial lung disease: A real-world pharmacovigilance analysis using FAERS dataHuahua Zhang, Yandong Zhang, Xiaoying Wang, et al.
Accident; Analysis and Prevention|February 8, 2024
Modeling and analyzing self-resistance of connected automated vehicular platoons under different cyberattack injection modesDongyu Luo, Jiangfeng Wang, Yu Wang, et al.
Future Oncology (London, England)|September 20, 2024
Cost-effectiveness of aumolertinib as first-line treatment for EGFR-mutated advanced nonsmall-cell lung cancerHuahua Zhang, Xiaochun Zheng, Yandong Zhang, et al.
Magnetic Resonance in Medicine|March 26, 2026
Integrating Local Precision With Global Consistency for Unsupervised Magnetic Resonance Image RegistrationHe Deng, Jiangfeng Wang, Xi Yin, et al.
BMJ Open|November 15, 2022
Neratinib plus capecitabine versus lapatinib plus capecitabine as the third-line therapy for HER2-positive metastatic breast cancer in China: a cost-effectiveness analysisYue Wu, Zhu Dong, Jiangfeng Wang, et al.
Clinical Drug Investigation|April 20, 2021
Cost-effectiveness Analysis of Trastuzumab Emtansine as Second-line Therapy for HER2-Positive Breast Cancer in ChinaHuahua Zhang, Yandong Zhang, Chaonan Huang, et al.
International Journal of Clinical Pharmacy|April 23, 2025
Pancreatitis associated with BRAF inhibitors: a disproportionality analysis based on the Food and Drug Administration Adverse Event Reporting SystemShoujun Wang, Jinjing Wang, Huahua Zhang, et al.
International Journal of Legal Medicine|February 14, 2016
Temperature-dependent development and the significance for estimating postmortem interval of Chrysomya nigripes Aubertin, a new forensically important species in ChinaLiangliang Li, Yu Wang, Jiangfeng Wang, et al.
Forensic Science International|March 7, 2018
Development of Musca domestica at constant temperatures and the first case report of its application for estimating the minimum postmortem intervalYu Wang, Lijun Yang, Yingna Zhang, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Scientific Reports|November 21, 2025
Research on vehicle trajectory planning algorithm integrating spatiotemporal constraints and adaptive curvatureYatao Zhao, Jiangfeng Wang, Peikun Li, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 7, 2025
HER2-targeted agents and interstitial lung disease: A real-world pharmacovigilance analysis using FAERS dataHuahua Zhang, Yandong Zhang, Xiaoying Wang, et al.
Accident; Analysis and Prevention|February 8, 2024
Modeling and analyzing self-resistance of connected automated vehicular platoons under different cyberattack injection modesDongyu Luo, Jiangfeng Wang, Yu Wang, et al.
Future Oncology (London, England)|September 20, 2024
Cost-effectiveness of aumolertinib as first-line treatment for EGFR-mutated advanced nonsmall-cell lung cancerHuahua Zhang, Xiaochun Zheng, Yandong Zhang, et al.
Magnetic Resonance in Medicine|March 26, 2026
Integrating Local Precision With Global Consistency for Unsupervised Magnetic Resonance Image RegistrationHe Deng, Jiangfeng Wang, Xi Yin, et al.
BMJ Open|November 15, 2022
Neratinib plus capecitabine versus lapatinib plus capecitabine as the third-line therapy for HER2-positive metastatic breast cancer in China: a cost-effectiveness analysisYue Wu, Zhu Dong, Jiangfeng Wang, et al.
Clinical Drug Investigation|April 20, 2021
Cost-effectiveness Analysis of Trastuzumab Emtansine as Second-line Therapy for HER2-Positive Breast Cancer in ChinaHuahua Zhang, Yandong Zhang, Chaonan Huang, et al.
International Journal of Clinical Pharmacy|April 23, 2025
Pancreatitis associated with BRAF inhibitors: a disproportionality analysis based on the Food and Drug Administration Adverse Event Reporting SystemShoujun Wang, Jinjing Wang, Huahua Zhang, et al.
International Journal of Legal Medicine|February 14, 2016
Temperature-dependent development and the significance for estimating postmortem interval of Chrysomya nigripes Aubertin, a new forensically important species in ChinaLiangliang Li, Yu Wang, Jiangfeng Wang, et al.
Forensic Science International|March 7, 2018
Development of Musca domestica at constant temperatures and the first case report of its application for estimating the minimum postmortem intervalYu Wang, Lijun Yang, Yingna Zhang, et al.
Pageof 11